118 related articles for article (PubMed ID: 28927903)
21. Synthesis and biophysical characterization of chlorambucil anticancer ether lipid prodrugs.
Pedersen PJ; Christensen MS; Ruysschaert T; Linderoth L; Andresen TL; Melander F; Mouritsen OG; Madsen R; Clausen MH
J Med Chem; 2009 May; 52(10):3408-15. PubMed ID: 19402667
[TBL] [Abstract][Full Text] [Related]
22. Novel molecular anti-colorectalcancer conjugate:chlorambucil-adipic acid dihydrizide-glutamine.
Tabasi MA; Amanlou M; Siadat SD; Nourmohammadi Z; Omoomi FD; Ebrahimi SE; Aghasadeghi MR; Rahimi P; Pourhosseini S; Mehravi B; Ardestani MS
Anticancer Agents Med Chem; 2013 Nov; 13(9):1449-59. PubMed ID: 23343080
[TBL] [Abstract][Full Text] [Related]
23. Sequence-specific DNA cleavage by dipeptides disubstituted with chlorambucil and 2,6-dimethoxyhydroquinone-3-mercaptoacetic acid.
Minnock A; Lin LS; Morgan J; Crow SD; Waring MJ; Sheh L
Bioconjug Chem; 2001; 12(6):870-82. PubMed ID: 11716676
[TBL] [Abstract][Full Text] [Related]
24. Albumin conjugates of the anticancer drug chlorambucil: synthesis, characterization, and in vitro efficacy.
Kratz F; Beyer U; Roth T; Schütte MT; Unold A; Fiebig HH; Unger C
Arch Pharm (Weinheim); 1998 Feb; 331(2):47-53. PubMed ID: 9525088
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin.
Christodoulopoulos G; Muller C; Salles B; Kazmi R; Panasci L
Cancer Res; 1998 May; 58(9):1789-92. PubMed ID: 9581813
[TBL] [Abstract][Full Text] [Related]
26. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.
Christodoulopoulos G; Malapetsa A; Schipper H; Golub E; Radding C; Panasci LC
Clin Cancer Res; 1999 Aug; 5(8):2178-84. PubMed ID: 10473103
[TBL] [Abstract][Full Text] [Related]
27. Amino and chlorambucil analogues of pentamidine--synthesis and biological examinations.
Pućkowska A; Drozdowska D; Rusak M; Bielawski T; Bruzgo I; Midura-Nowaczek K
Acta Pol Pharm; 2012; 69(1):63-73. PubMed ID: 22574508
[TBL] [Abstract][Full Text] [Related]
28. A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers.
Millard M; Gallagher JD; Olenyuk BZ; Neamati N
J Med Chem; 2013 Nov; 56(22):9170-9. PubMed ID: 24147900
[TBL] [Abstract][Full Text] [Related]
29. A novel delocalized lipophilic cation-chlorambucil conjugate inhibits P-glycoprotein in HepG2/ADM cells.
Liu T; Peng Y; Li X; Liu L; Liu F; He L
Bioorg Med Chem; 2017 Oct; 25(20):5461-5467. PubMed ID: 28818459
[TBL] [Abstract][Full Text] [Related]
30. Alkylation of a human telomere sequence by heterotrimeric chlorambucil PI polyamide conjugates.
Kashiwazaki G; Bando T; Shinohara K; Minoshima M; Kumamoto H; Nishijima S; Sugiyama H
Bioorg Med Chem; 2010 Apr; 18(8):2887-93. PubMed ID: 20350810
[TBL] [Abstract][Full Text] [Related]
31. Structure-anti-leukemic activity relationship study of B- and D-ring modified and non-modified steroidal esters of chlorambucil.
Fousteris MA; Koutsourea AI; Arsenou ES; Papageorgiou A; Mourelatos D; Nikolaropoulos SS
Anticancer Drugs; 2006 Jun; 17(5):511-9. PubMed ID: 16702807
[TBL] [Abstract][Full Text] [Related]
32. Targeted combinational therapy inducing mitochondrial dysfunction.
Shin WS; Park SK; Verwilst P; Koo S; Lee JH; Chi SG; Kim JS
Chem Commun (Camb); 2017 Jan; 53(7):1281-1284. PubMed ID: 28067351
[TBL] [Abstract][Full Text] [Related]
33. SAR study of tyrosine-chlorambucil hybrid regioisomers; synthesis and biological evaluation against breast cancer cell lines.
Descôteaux C; Brasseur K; Leblanc V; Parent S; Asselin E; Bérubé G
Amino Acids; 2012 Aug; 43(2):923-35. PubMed ID: 22102055
[TBL] [Abstract][Full Text] [Related]
34. Arresting cancer proliferation by small-molecule gene regulation.
Dickinson LA; Burnett R; Melander C; Edelson BS; Arora PS; Dervan PB; Gottesfeld JM
Chem Biol; 2004 Nov; 11(11):1583-94. PubMed ID: 15556009
[TBL] [Abstract][Full Text] [Related]
35. Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia.
Bello VE; Aloyz RS; Christodoulopoulos G; Panasci LC
Biochem Pharmacol; 2002 May; 63(9):1585-8. PubMed ID: 12007561
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and anticancer evaluation of novel oncolytic peptide-chlorambucil conjugates.
Yin H; Fu XY; Gao HY; Ma YN; Yao JF; Du SS; Qi YK; Wang KW
Bioorg Chem; 2023 Sep; 138():106674. PubMed ID: 37331169
[TBL] [Abstract][Full Text] [Related]
37. Stepwise dual stimuli triggered dual drug release by a single naphthalene based two-photon chromophore to reverse MDR for alkylating agents with dual surveillance in uncaging steps.
Roy B; Kundu M; Singh AK; Singha T; Bhattacharya S; Datta PK; Mandal M; Singh NDP
Chem Commun (Camb); 2019 Oct; 55(87):13140-13143. PubMed ID: 31617528
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antitumor activity of novel paclitaxel-chlorambucil hybrids.
Wittman MD; Kadow JF; Vyas DM; Lee FL; Rose WC; Long BH; Fairchild C; Johnston K
Bioorg Med Chem Lett; 2001 Mar; 11(6):811-4. PubMed ID: 11277526
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and preliminary in vitro biological evaluation of 7α-testosterone-chlorambucil hybrid designed for the treatment of prostate cancer.
Bastien D; Hanna R; Leblanc V; Asselin É; Bérubé G
Eur J Med Chem; 2013 Jun; 64():442-7. PubMed ID: 23665800
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".
Lampidis TJ; Kurtoglu M; Maher JC; Liu H; Krishan A; Sheft V; Szymanski S; Fokt I; Rudnicki WR; Ginalski K; Lesyng B; Priebe W
Cancer Chemother Pharmacol; 2006 Dec; 58(6):725-34. PubMed ID: 16555088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
